Copaxone and Revlimid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Copaxone (glatiramer acetate) and Revlimid (lenalidomide). Common drug interactions include diarrhoea among females and hiccups among males.

The phase IV clinical study analyzes what interactions people have when they take Copaxone and Revlimid. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Copaxone?

Copaxone has active ingredients of glatiramer acetate. It is often used in multiple sclerosis. eHealthMe is studying from 56,931 Copaxone users. Check the latest studies of Copaxone.

What is Revlimid?

Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 378,026 Revlimid users. Check the latest studies of Revlimid.

On Aug, 08, 2026

33 people who take Copaxone and Revlimid together, and have interactions are studied.

Copaxone and Revlimid drug interactions.

What are the common drug interactions of Copaxone and Revlimid, by gender? *:

female:

Diarrhoea
Pneumonia
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Nasopharyngitis (inflammation of the nasopharynx)
Loss of consciousness
Papule
Platelet count decreased
Aggression
Anaemia (lack of blood)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)

male:

Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough)
Hypercalcaemia (elevated calcium (ca+) level in the blood)
Eye disorder
Limb injury
Migraine (headache)
Nausea (feeling of having an urge to vomit)
Urinary tract infection
Renal impairment (severely reduced kidney function)
Spinal compression fracture (fracture due to spinal compression on bone)
Cataract (clouding of the lens inside the eye)

What are the common drug interactions of Copaxone and Revlimid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Febrile neutropenia (fever with reduced white blood cells)
Loss of consciousness
Pneumonia
Septic shock (shock due to blood infection)

40-49:

Migraine (headache)
Urinary tract infection

50-59:

Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough)
Hypercalcaemia (elevated calcium (ca+) level in the blood)
Renal impairment (severely reduced kidney function)
Spinal compression fracture (fracture due to spinal compression on bone)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Diarrhoea
Fall
Laceration (tearing of soft body tissue)
Palpitations (feelings or sensations that your heart is pounding or racing)
Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)

60+:

Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Diarrhoea
Chills (felling of cold)
Confusional state
Erythema (redness of the skin)
Feeling hot
Hypersensitivity
Limb injury
Loss of consciousness
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

What are the existing conditions these people have? *

Pain: 4 people, 12.12%
Nausea (feeling of having an urge to vomit): 3 people, 9.09%
Sleep Disorder: 2 people, 6.06%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 6.06%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 6.06%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 6.06%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Copaxone and Revlimid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously